Ro-281675

SynDRA canonical compound SYN0021934 — structure-anchored drug synonym record

Clinical phase	Preclinical
Primary target(s)	GCK
Mechanism of action	Glucokinase activator

All known targets

GCK

Mechanisms of action (all sources)

Glucokinase activator

Cross-references

PubChem CID: 9886086
ChEMBL: CHEMBL1096435
ChEBI: 95004
PDB: 4DC
LINCS BRD: BRD-K21672174

Synonyms

Ro-28-1675
RO-28-1675
C18H22N2O3S2
RO-0281675
NEQSWPCDHDQINX-MRXNPFEDSA-N
orb1706690
SCHEMBL2645615
CHEBI:95004
GLXC-04289
BDBM50346020
MFCD12546328
AKOS030526774
DA-67253
HY-10595
MS-26184
Ro 28-1675?
(R)-RO 28-0450
RO-181675
E98859
T16793
RO-181675-000
BRD-K21672174-001-01-4
BRD-K21672174-001-03-0
4DC
(2R)-3-cyclopentyl-2-(4-methylsulfonylphenyl)-N-(2-thiazolyl)propanamide
Ro 0281675
(2R)-3-Cyclopentyl-2-[4-(methanesulfonyl)phenyl]-N-(thiazol-2-yl)propionamide

Look up Ro-281675 in the interactive SynDRA portal →